JPRN-UMIN000000514已完成4 期
Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast Cancer - Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast Cancer (SAFE program: Saitama Anastrozole related Fracture Evaluation program)
Saitama Breast Cancer Clinical Study Group (SBCCSG)0 个研究点目标入组 350 人开始时间: 2006年11月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Active multiple cancer (simultaneous multiple cancer, and multi-organ invasive cancer with less than 5years of event-free survival) 2. Non-invasive cancer, inflammatory breast cancer 3. Patients with history of osteoporosis or BMD is osteoporosis level (less than 70% of young adult mean (YAM)) 4. Patients being treated with bisphosphonate drugs or other osteoporotic drugs 5. Patients diagnosed as having a history of spinal fracure in X-ray or other imagin tests 6. Serious complications (hepatic, renal, cardiac, and endocrine diseases, etc.) 7. Patients with a history of hypersensitivity to any of the ingredients of the study drug 8. Patients judged to be ineligible for participating in the study by investigators
研究者
相似试验
已完成
不适用
Clinical study of postoperative adjuvant therapy in locally advanced oral squamous cell carcinomaoral squamous cell carcinomaJPRN-UMIN000033453agasaki University50
招募中
不适用
Feasibility study of postoperative adjuvant therapy using S-1 after curative esophagectomy for esophageal cancerEsophageal cancerJPRN-jRCT1060220042Hirahara Noriyuki45
进行中（未招募）
1 期
Evaluation of postoperative administration of tranexamic acid on reducing blood loss after hip prothesis surgery.surgery for hip prosthesis or for hip prosthesis replacementMedDRA version: 18.0Level: LLTClassification code 10044088Term: Total hip replacementSystem Organ Class: 100000004865EUCTR2013-000791-15-FRCHU de Saint-Etienne168
已完成
1 期
Phase I/II study of postoperative adjuvant therapy with Gemcitabine plus peptide vaccine for pancreatic cancer.Pancreatic cancerJPRN-UMIN000004332Tokyo Women's Medical University20
招募中
2 期
A feasibility study of postroperative adjuvant chemotherapy using platinum-based chemotherapy followed by maintenance TS-1 for completely resected pathologic stage II-IIIA non-small cell lung cancer with a biomarker study of circulating tumor cellCompletely resected pathologic stage II-IIIA non-small cell lung cancerJPRN-UMIN000002592DEPARTMENT OF THORACIC SURGERY, HYOGO COLLEGE OF MEDICINE40